Tirzepatide 'shot day' content: what the science says

What did @itsmamacookie actually say?

She's on her 21st weekly tirzepatide injection, has dropped from 253 to 219 pounds, and is sharing what she calls her honest, unpaid testimony. The practical list she rattles off includes taking a multivitamin, drinking electrolytes "two or three times a day," prioritizing protein, skipping intermittent fasting, working out to prevent muscle loss, and using alcohol wipes to avoid infection. She also notes her nausea side effects faded after about two months.

This is personal experience content, not medical advice, and she says so clearly. But with nearly half a million views, what she says carries real weight, so it's worth checking whether her tips actually hold up.

Does the science back this up?

More than you might expect. The core advice, protein intake, hydration, electrolytes, and resistance exercise, is genuinely supported by the clinical literature on GLP-1 and dual GIP/GLP-1 agonists like tirzepatide.

The muscle loss concern she raises is real and not talked about enough. A 2023 analysis by Wilding et al. in Diabetes, Obesity and Metabolism noted that participants on tirzepatide lost significant lean mass alongside fat mass, which is why resistance training is increasingly recommended as a co-intervention. Her line, "your muscles will turn into flaps," is colorful but the underlying concern is legitimate.

On electrolytes: GLP-1 receptor agonists reduce food and fluid intake significantly. Reduced sodium and potassium intake is a predictable downstream effect. There is no specific trial proving two-to-three electrolyte drinks daily is the right number, but her logic is sound. The protein push is also supported. Davies et al. (2021, Lancet) showed tirzepatide users eating substantially less overall, making intentional protein targeting a reasonable harm-reduction strategy.

What did they get wrong (or right)?

She got more right than wrong, but a few things need flagging.

Calling intermittent fasting "stupid as fuck" is an overreach. It is not stupid. Timed eating protocols have independent metabolic evidence behind them, and some clinicians use them alongside GLP-1 therapy. The real issue is that fasting on a drug that already suppresses appetite can make it easier to under-eat protein and calories to a problematic degree. That is a legitimate concern, but fasting itself is not the villain she makes it out to be.

The "five or two to three times a day" fragment in the transcript is garbled, but appears to reference protein intake frequency, not dosing. Worth noting: she never tells anyone what dose to take, which is actually responsible.

Her injection site rotation advice, left to right beside the belly button, is reasonable. The abdomen, thigh, and upper arm are all validated sites per prescribing guidance. Thigh injections are clinically fine, so her personal preference is not a problem, just a preference.

Credit where it is due: she mentions a named physician and is taking the audience to a documented appointment. That kind of accountability is rare in this content category.

What should you actually know?

Tirzepatide (brand names Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP and GLP-1 receptor agonist approved by the FDA. It is not a simple appetite suppressant. It works on multiple metabolic pathways and requires medical supervision because it interacts with blood sugar regulation, thyroid history, and several other conditions.

The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed an average weight reduction of up to 22.5 percent of body weight over 72 weeks in people without diabetes. That is the clinical benchmark. Individual results vary significantly based on dose, adherence, diet, and activity.

If you are considering tirzepatide, the practical list she gives, protein, hydration, electrolytes, multivitamin, exercise, alcohol wipes for injection hygiene, is not bad as a starting framework. But it does not replace a clinical intake, a review of your medication list, or understanding that nausea, vomiting, and gastrointestinal distress are documented side effects that warrant medical follow-up if severe.

Her two-month nausea window aligns with what trials document as the dose-escalation adjustment period. That is not universal, and if your symptoms are severe or prolonged, that is a call to your prescriber, not something to push through.